The finding that DERL3-hypermethylated cancer cells were highly sensitive to shikonin, and that restoration of DERL3 expression induced resistance to this drug was further confirmed by an MTT growth inhibition curve, the SRB (Sulforhodamine B) assay and colony formation experiments (Supplementary Fig. 9). This evidence concerns the gene DERL3 and cancer.